Stay updated on Nivolumab With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.7%
    Check dated 2025-05-07T19:44:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.9%
    Check dated 2025-04-30T14:25:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-04-23T13:50:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new types of leukemia and clinical trial identifiers, while significant details about the study's design and participant criteria have been removed.
    Difference
    47%
    Check dated 2025-04-16T11:10:08.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T05:16:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Acute Leukemia of Ambiguous Lineage and has revised its version number to v2.14.3, while removing references to Juvenile Myelomonocytic Leukemia and the previous version v2.14.2.
    Difference
    0.6%
    Check dated 2025-04-01T22:25:27.000Z thumbnail image

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.